Study on the role and efficacy of Triphala Ghrita Aschyotan in Vataj Abhishyanda w.r.t Allergic Conjunctivitis
Keywords:Allergic Conjunctivitis, Vataj Abhishyanda, Triphala Ghrita, Aschyotana, Ketotifen Fumarate
Allergic conjunctivitis is a common ophthalmic problem predominantly affecting the outdoor workers. The eyes are exposed to different environmental factors. The eye and eyelids are very common sites for allergic reactions. About 50% of conjunctivitis seen by primary physicians is allergic in nature. Vataj Abhishyanda is a clinical entity which can be correlated with allergic conjunctivitis. Triphala Ghrita Aschyotan helps to relieve the symptoms of Vataj Abhishyand w.r.t allergic conjunctivitis. Triphala Ghrita is a Vyadhi Pratyanik Dravya and helpful in topical eye allergies. Aim: To study the role and efficacy of Triphala Ghrita Aschyotan in Vataj Abhishyanda w.r. t. allergic conjunctivitis. Materials and Method: A total 60 patients of the age group 15-60 years presenting with signs and symptoms of Vataj Abhishyanda w.r.t allergic conjunctivitis were selected randomly from OPD of the department of Shalakyatantra, Government Ayurved College, Nanded (M.S.) within inclusion criteria and were treated in two groups. The 30 patients of trial group were treated with Triphala Ghrita Aschyotana and patients of control group in similar number were subjected to Ketotifen Fumarate eye drop. Results: The trial drug Triphala Ghrita is equally effective as compared to Ketotifen eye drop. Trial drug provided more relief in symptoms like Sangharsha (Itching of eyes), which is the parameter of efficacy. Conclusion:Triphala Ghrita Aschyotan is an effective, safe and potent treatment of Vataj Abhishyanda w.r.t allergic conjunctivitis.
How to Cite
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.